Empowering scholars to blaze a STEM2D trail
We strive to advance bold, life-changing programs - in collaboration with a global community of vital academic institutions and partners - to remove barriers and create a sustainable movement for the advancement of women in STEM2D degrees, research and beyond.
Scholars Award Program
The Johnson & Johnson Scholars Award Program aims to fuel development of women leaders in STEM2D and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their careers in each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design.
Hear from our first Scholars Award Winners
-
I am thrilled to be selected as a WiSTEM2D awardee! This early career support will grant me the independence and flexibility to move my research program forward and pursue research that I am passionate about.
Lauren Stadler, Ph.D.Assistant Professor of Civil and Environmental Engineering, Rice University -
I am grateful to be an inaugural recipient of the Johnson & Johnson Women in STEM2D Award, which helps provide much-needed support and encouragement for women, such as myself, in historically male-dominated fields of math, science and engineering.
Soojung Claire HurClare Boothe Luce Assistant Professor of Mechanical Engineering, Whiting School of Engineering, Johns Hopkins University -
Being an inaugural Johnson & Johnson WiSTEM2D scholar is an incredible honor. I’m excited for the unique resources this award will provide to my own research program as well as the opportunity to work with Johnson & Johnson to maximize the potential of other women in science.
Seemay Chou, Ph.D.Assistant Professor in Biochemistry and Biophysics, University of California San Francisco
Supporting undergrads
We seek to positively influence and impact undergraduate students worldwide by bridging the path to rewarding careers that will advance women in STEM higher education.
By developing relationships with universities and initiating interactions with students pursuing education in STEM2D fields, we are expanding our reach, programming, and impact on university students across the world. This is accomplished by organizing events and activities with partner universities such as college-to-career programs, panel discussions, guest speakers, innovation challenges, mentoring opportunities, site visits, and more.
By developing relationships with universities and initiating interactions with students pursuing education in STEM2D fields, we are expanding our reach, programming, and impact on university students across the world. This is accomplished by organizing events and activities with partner universities such as college-to-career programs, panel discussions, guest speakers, innovation challenges, mentoring opportunities, site visits, and more.
-
We are enthusiastic about working with prestigious institutions to expand interest in STEM2D fields while fostering diversified perspectives across the world. At the undergraduate level, we aspire to increase the number of women entering and graduating from four-year undergraduate programs with STEM2D degrees. At the graduate level, we aspire to increase the number of women pursuing advanced academic careers in STEM2D.
Cat OylerVice President, Global Public Health
More from Johnson & Johnson
Inside the development of a revolutionary treatment for blood cancers
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
“I’m a scientist dedicated to bringing eye-health innovations to the world”
Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.